Fundz

Design Therapeutics, Inc. reported raising $45.5 Million in an initial SEC Form D filing, from an offering of $45.5 Million

PUBLIC · DSGNMar 20, 2020

Amount Raised

$45.5 Million

$45.5 Million sold, per SEC Form D (first sale Mar 20, 2020)

Round Type

Venture

CarlsbadBiotechnologyHealthcareHealth CareTherapeutics

Quick answer

Design Therapeutics, Inc. raised $45.5 Million in a funding round, dated March 20, 2020. Design Therapeutics, Inc. is based in Carlsbad, California, United States.

How much did Design Therapeutics, Inc. raise?
Design Therapeutics, Inc. raised $45.5 Million in a funding round on March 20, 2020.
What does Design Therapeutics, Inc. do?
Design Therapeutics is a biotechnology company developing a new class of therapies based on a platform of gene targeted chimera (GeneTAC™) small molecules.
Where is Design Therapeutics, Inc. based and how big is it?
Design Therapeutics, Inc. is based in Carlsbad, California, United States.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Design Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Os Therapies raised an undisclosed amount on May 1, 2020.
  • Phio Pharmaceuticals raised $4.4M on April 14, 2020.
  • Crispr Therapeutics raised $1M (Seed) on April 9, 2020.
  • CytoDyn raised $882K (Seed) on March 30, 2020.
  • Olema Pharmaceuticals, Inc. raised $30M on March 27, 2020.
  • Verastem Oncology raised $100M on March 6, 2020.

Who to call at Design Therapeutics, Inc., and when

A new round usually means Design Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Design Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Design Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Design Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Design Therapeutics, Inc.

Location

991C LOMAS SANTA FE #436

Carlsbad, California, United States

About

Design Therapeutics is a biotechnology company developing a new class of therapies based on a platform of gene targeted chimera (GeneTAC™) small molecules. The company’s lead program is focused on the treatment of Friedreich ataxia, followed by a program in myotonic dystrophy type-1 and discovery efforts for multiple other serious degenerative disorders caused by nucleotide repeat expansions. For more information, please visit designtx.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Design Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Design Therapeutics, Inc.'s next move

See what Strategic adds

Design Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.